SCHEMBL26091035

SCHEMBL26091035

NC(=O)OCc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.67
▸ GSPT1 P15170 3/20 0.55
▸ CSNK1A1 P48729 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737958 0.92 CRBN (0.67) CRBNGSPT1CSNK1A1
SCHEMBL26739486 0.91 CRBN (0.66) CRBNGSPT1
SCHEMBL26740208 0.87 CRBN (0.61) CRBNGSPT1
SCHEMBL24828772 0.87 CRBN (0.69) CRBNGSPT1
SCHEMBL26740201 0.86 CRBN (0.60) CRBNGSPT1
SCHEMBL24250681 0.86 CRBN (0.68) CRBNGSPT1
SCHEMBL27290606 0.86 CRBN (0.59) CRBNGSPT1CSNK1A1
SCHEMBL26740215 0.86 CRBN (0.59) CRBNGSPT1CSNK1A1
SCHEMBL26740198 0.86 CRBN (0.59) CRBNGSPT1CSNK1A1
SCHEMBL29739711 0.85 CRBN (0.58) CRBNGSPT1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069720-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback